Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up.

Rihito AizawaKiyonao NakamuraYoshiki NorihisaTakashi OgataTakahiro InoueToshinari YamasakiTakashi KobayashiShusuke AkamatsuOsamu OgawaTakashi Mizowaki

Published in: International journal of clinical oncology (2021)

WP-SIB-IMRT for LAPCa was safe over long-term observation, although no clear benefit of WPRT was observed among our small and highly selected cohort. Regarding the additional efficacy of WPRT, further investigations are needed.

Keyphrases

prostate cancer
high dose
radical prostatectomy
low dose
rectal cancer
stem cell transplantation